NRIX – nurix therapeutics, inc. - common stock (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

NRIX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/17

08:21 am

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

3/17

08:11 am

nrix

Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at Leerink Partners. They set a "market perform" rating and a $16.00 price target on the stock.

Low Report

Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at Leerink Partners. They set a "market perform" rating and a $16.00 price target on the stock.

Report

3/17

06:19 am

nrix

Nurix Therapeutics initiated with a Market Perform at Leerink

Low Report

Nurix Therapeutics initiated with a Market Perform at Leerink

Report

2/3

07:53 am

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

2/3

07:53 am

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

1/29

12:26 pm

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

1/29

12:26 pm

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

1/29

08:56 am

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

1/29

08:17 am

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

1/29

07:18 am

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

1/29

07:18 am

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

1/21

12:46 pm

nrix

Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $31.00 price target on the stock.

Low Report

Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $31.00 price target on the stock.

Report

1/21

12:46 pm

nrix

Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $31.00 price target on the stock.

Low Report

Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $31.00 price target on the stock.

Report

1/21

12:42 pm

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.